Loqtorzi (toripalimab)

pCPA File Number: 23499

Negotiation Status:

Under consideration for negotiation

Indication(s):

for the treatment of adults with recurrent unresectable or metastatic nasopharyngeal carcinoma (NPC) with disease progression on or after a platinum-containing chemotherapy

Sponsor/Manufacturer:

Apotex Inc.

CDA-AMC Project Number:

PC0423-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable